These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28540308)

  • 1. Relationships between Composition of Major Fatty Acids and Fat Distribution and Insulin Resistance in Japanese.
    Fujii C; Kawai T; Azuma K; Oguma Y; Katsukawa F; Hirose H; Tanaka K; Meguro S; Matsumoto H; Itoh H
    J Diabetes Res; 2017; 2017():1567467. PubMed ID: 28540308
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients.
    Taniguchi A; Nakai Y; Sakai M; Yoshii S; Hamanaka D; Hatae Y; Kawata M; Yamanouchi K; Okumura T; Doi K; Tokuyama K; Nagasaka S; Fukushima M
    Metabolism; 2002 May; 51(5):544-8. PubMed ID: 11979383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the serum concentrations of C-reactive protein and parameters of adiposity and insulin resistance in patients with type 2 diabetes mellitus.
    Iwasaki T; Nakajima A; Yoneda M; Terauchi Y
    Endocr J; 2006 Jun; 53(3):345-56. PubMed ID: 16714840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men.
    Mori Y; Hoshino K; Yokota K; Yokose T; Tajima N
    Exp Clin Endocrinol Diabetes; 2005 Jun; 113(6):334-9. PubMed ID: 15977101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating preptin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects.
    Yang G; Li L; Chen W; Liu H; Boden G; Li K
    Ann Med; 2009; 41(1):52-6. PubMed ID: 18618352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance.
    Nagaretani H; Nakamura T; Funahashi T; Kotani K; Miyanaga M; Tokunaga K; Takahashi M; Nishizawa H; Kishida K; Kuriyama H; Hotta K; Yamashita S; Matsuzawa Y
    Diabetes Care; 2001 Dec; 24(12):2127-33. PubMed ID: 11723095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant correlation between visceral adiposity and high-sensitivity C-reactive protein (hs-CRP) in Japanese subjects.
    Tsuriya D; Morita H; Morioka T; Takahashi N; Ito T; Oki Y; Nakamura H
    Intern Med; 2011; 50(22):2767-73. PubMed ID: 22082888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese-Americans with normal fasting glucose.
    Liao D; Shofer JB; Boyko EJ; McNeely MJ; Leonetti DL; Kahn SE; Fujimoto WY
    Diabetes Care; 2001 Jan; 24(1):39-44. PubMed ID: 11194238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose Tissue Insulin Resistance in Youth on the Spectrum From Normal Weight to Obese and From Normal Glucose Tolerance to Impaired Glucose Tolerance to Type 2 Diabetes.
    Kim JY; Bacha F; Tfayli H; Michaliszyn SF; Yousuf S; Arslanian S
    Diabetes Care; 2019 Feb; 42(2):265-272. PubMed ID: 30455334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance.
    Borel AL; Nazare JA; Smith J; Aschner P; Barter P; Van Gaal L; Eng Tan C; Wittchen HU; Matsuzawa Y; Kadowaki T; Ross R; Brulle-Wohlhueter C; Alméras N; Haffner SM; Balkau B; Després JP
    Int J Obes (Lond); 2015 Mar; 39(3):495-501. PubMed ID: 25179244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between ultrasound measures of abdominal fat distribution and indices of glucose metabolism in a population at high risk of type 2 diabetes: the ADDITION-PRO study.
    Philipsen A; Jørgensen ME; Vistisen D; Sandbaek A; Almdal TP; Christiansen JS; Lauritzen T; Witte DR
    PLoS One; 2015; 10(4):e0123062. PubMed ID: 25849815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation--double-blind placebo-controlled trial.
    Nakamura T; Funahashi T; Yamashita S; Nishida M; Nishida Y; Takahashi M; Hotta K; Kuriyama H; Kihara S; Ohuchi N; Nishimura T; Kishino BI; Ishikawa K; Kawamoto T; Tokunaga K; Nakagawa C; Mineo I; Watanabe F; Tarui S; Matsuzawa Y
    Diabetes Res Clin Pract; 2001 Dec; 54(3):181-90. PubMed ID: 11689273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty liver disease, glucose tolerance and insulin resistance in obese adolescents.
    Slyper AH; Rosenberg H; Kabra A; Huang WM; Blech B; Matsumura MM
    Pediatr Obes; 2015 Dec; 10(6):423-7. PubMed ID: 25522002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of liraglutide, a human glucagon-like peptide-1 analogue, on body weight, body fat area and body fat-related markers in patients with type 2 diabetes mellitus.
    Suzuki D; Toyoda M; Kimura M; Miyauchi M; Yamamoto N; Sato H; Tanaka E; Kuriyama Y; Miyatake H; Abe M; Umezono T; Fukagawa M
    Intern Med; 2013; 52(10):1029-34. PubMed ID: 23676586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fat redistribution and accumulation of visceral adipose tissue predicts type 2 diabetes risk in middle-aged black South African women: a 13-year longitudinal study.
    Mtintsilana A; Micklesfield LK; Chorell E; Olsson T; Goedecke JH
    Nutr Diabetes; 2019 Mar; 9(1):12. PubMed ID: 30918247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of impaired glucose tolerance in Japanese Americans: Change in visceral adiposity is associated with remission from impaired glucose tolerance to normal glucose tolerance.
    Onishi Y; Hayashi T; Sato KK; Leonetti DL; Kahn SE; Fujimoto WY; Boyko EJ
    Diabetes Res Clin Pract; 2018 Aug; 142():303-311. PubMed ID: 29859271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes.
    Fukushima M; Usami M; Ikeda M; Nakai Y; Taniguchi A; Matsuura T; Suzuki H; Kurose T; Yamada Y; Seino Y
    Metabolism; 2004 Jul; 53(7):831-5. PubMed ID: 15254872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
    Snehalatha C; Ramachandran A; Satyavani K; Latha E; Viswanathan V
    Diabetes Care; 1998 Jan; 21(1):76-9. PubMed ID: 9538973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pioglitazone on visceral fat metabolic activity in impaired glucose tolerance or type 2 diabetes mellitus.
    Kodama N; Tahara N; Tahara A; Honda A; Nitta Y; Mizoguchi M; Kaida H; Ishibashi M; Abe T; Ikeda H; Narula J; Fukumoto Y; Yamagishi S; Imaizumi T
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4438-45. PubMed ID: 24030946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of the thickness of preperitoneal and subcutaneous fat layer in the abdomen estimated by ultrasonography for diagnosing abdominal obesity in each type of impaired glucose tolerance in man.
    Soyama A; Nishikawa T; Ishizuka T; Ito H; Saito J; Yagi K; Saito Y
    Endocr J; 2005 Apr; 52(2):229-36. PubMed ID: 15863953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.